Our team has developed tiny gelatin nanoparticles that can carry medication to the brain, which could lead to longer treatment windows for stroke patients. Gelatin nanoparticles could be laced with medications for delivery to the brain, and that they could extend the treatment window for when a drug could be effective. Gelatin is biocompatible, biodegradable, and classified as "Generally Recognized as Safe" by the Food and Drug Administration. Once administered, the gelatin nanoparticles target damaged brain tissue thanks to an abundance of gelatin-munching enzymes produced in injured regions.
12/23/2014